David Sourdive, Ph.D., is a co-founder of Cellectis and joined the Board of Directors in 2000. Dr.
Sourdive combines a strong scientific expertise with experience in managing industrial programs
bringing innovative technologies to industrial fruition. He served as Executive Vice President,
Corporate Development, from 2008 to 2016 and as Executive Vice President, Technical Operations
until July 2019. In addition to his role at Cellectis, Dr. Sourdive has also served on the board of directors
of the Mediterranean Institute for Life Sciences. David Sourdive graduated from École Polytechnique,
received his Ph.D. in molecular virology at Institut Pasteur and completed a research fellowship in the
Emory University Department of Microbiology and Immunology. His management training is from
the HEC (Challenge +) and his decade-long experience in industrial program management was acquired
at the French Department of Defense (DGA) prior to Cellectis’ inception.
